CN Patent

CN114072501A — 抗c9orf72寡核苷酸及相关方法

Assigned to University of Massachusetts Amherst · Expires 2022-02-18 · 4y expired

What this patent protects

本公开内容提供了用于使C9ORF72转录物沉默的反义化合物、方法和组合物。本公开内容提供了用于在有此需要的对象中治疗、预防或减轻与C9ORF72相关的疾病、障碍和病症的反义化合物、方法和组合物。还考虑了用于制备用于治疗、预防或减轻与C9ORF72相关的疾病、障碍或病症的药物的反义化合物和方法。

USPTO Abstract

本公开内容提供了用于使C9ORF72转录物沉默的反义化合物、方法和组合物。本公开内容提供了用于在有此需要的对象中治疗、预防或减轻与C9ORF72相关的疾病、障碍和病症的反义化合物、方法和组合物。还考虑了用于制备用于治疗、预防或减轻与C9ORF72相关的疾病、障碍或病症的药物的反义化合物和方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN114072501A
Jurisdiction
CN
Classification
—
Expires
2022-02-18
Drug substance claim
No
Drug product claim
No
Assignee
University of Massachusetts Amherst
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.